{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:20Z","timestamp":1761100520051},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,10,1]]},"DOI":"10.1038\/sj.bmt.1702596","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:47:56Z","timestamp":1031154476000},"page":"769-774","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome"],"prefix":"10.1038","volume":"26","author":[{"given":"S","family":"Shiobara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Maruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Gondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,10,10]]},"reference":[{"key":"BF1702596_CR1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 1990 76: 2462\u20132465","journal-title":"Blood"},{"key":"BF1702596_CR2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood.V79.5.1379.1379","volume":"79","author":"JO Collis","year":"1992","unstructured":"Collis JO, Jiang YZ, Schwarer AP et al. Donor leukocyte infusions for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation Blood 1992 79: 1379\u20131380","journal-title":"Blood"},{"key":"BF1702596_CR3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","volume":"82","author":"WR Drobyski","year":"1993","unstructured":"Drobyski WR, Keever CA, Roth MS et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation; efficiency and toxicity of a defined T-cell dose Blood 1993 82: 2310\u20132318","journal-title":"Blood"},{"key":"BF1702596_CR4","first-page":"125","volume":"12","author":"C Helg","year":"1993","unstructured":"Helg C, Roux E, Beris P et al. Adoptive immunotherapy for recurrent CML after BMT Bone Marrow Transplant 1993 12: 125\u2013129","journal-title":"Bone Marrow Transplant"},{"key":"BF1702596_CR5","first-page":"1553","volume":"23","author":"S Slavin","year":"1995","unstructured":"Slavin S, Naparstek E, Naglar A et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp Hematol 1995 23: 1553\u20131562","journal-title":"Exp Hematol"},{"key":"BF1702596_CR6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF1702596_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins","year":"1997","unstructured":"Collins RH, Shpilberg JO, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433\u2013444","journal-title":"J Clin Oncol"},{"key":"BF1702596_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts New Engl J Med 1979 300: 1068\u20131073","journal-title":"New Engl J Med"},{"key":"BF1702596_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM198903303201303","volume":"320","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Storb R, Buckner CD et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms New Engl J Med 1989 320: 828\u2013834","journal-title":"New Engl J Med"},{"key":"BF1702596_CR10","first-page":"235","volume":"15","author":"Y Morishima","year":"1995","unstructured":"Morishima Y, Kodera Y, Hirabayashi N et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese Bone Marrow Transplant 1995 15: 235\u2013239","journal-title":"Bone Marrow Transplant"},{"key":"BF1702596_CR11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","volume":"22","author":"T Sasazuki","year":"1998","unstructured":"Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program New Engl J Med 1998 22: 1177\u20131185","journal-title":"New Engl J Med"},{"key":"BF1702596_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.bmt.1702027","volume":"24","author":"Y Kodera","year":"1999","unstructured":"Kodera Y, Morishima Y, Kato S et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia Bone Marrow Transplant 1999 24: 995\u20131003","journal-title":"Bone Marrow Transplant"},{"key":"BF1702596_CR13","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","volume":"91","author":"EP Alyea","year":"1998","unstructured":"Alyea EP, Soiffer RJ, Canning C et al. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant Blood 1998 91: 3671\u20133680","journal-title":"Blood"},{"key":"BF1702596_CR14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","volume":"87","author":"S Slavin","year":"1996","unstructured":"Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation Blood 1996 87: 2195\u20132204","journal-title":"Blood"},{"key":"BF1702596_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bmt.1701123","volume":"21","author":"H Ogawa","year":"1998","unstructured":"Ogawa H, Tsuboi A, Oji Y et al. Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogenic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay Bone Marrow Transplant 1998 21: 525\u2013527","journal-title":"Bone Marrow Transplant"},{"key":"BF1702596_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bmt.1700663","volume":"19","author":"M Yazaki","year":"1997","unstructured":"Yazaki M, Andou M, Ito T et al. Successful prevention of hematological relapse for a patient with Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion Bone Marrow Transplant 1997 19: 393\u2013394","journal-title":"Bone Marrow Transplant"},{"key":"BF1702596_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1046\/j.1537-2995.1995.35495216075.x","volume":"35","author":"FF Wagner","year":"1995","unstructured":"Wagner FF, Flegel WA . Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotype Transfusion 1995 35: 284\u2013291","journal-title":"Transfusion"},{"key":"BF1702596_CR18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261\u20131268","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702596","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:47:34Z","timestamp":1648075654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,10,1]]}},"alternative-id":["BF1702596"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702596","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10,1]]},"assertion":[{"value":"21 February 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}